Gilead Still A 'Top Pick' For Barclays
May 01, 2015 at 06:46 AM EDT
In a report published Friday, Barclays analysts maintained an Overweight rating on Gilead Sciences Inc (NASDAQ: GILD), with a price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.